Immediate Impact
86 standout
Citing Papers
Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression
2024 Standout
Patient-derived tumor organoids: a new avenue for preclinical research and precision medicine in oncology
2024 Standout
Works of Luca Russo being referenced
Establishment and Morphological Characterization of Patient-Derived Organoids from Breast Cancer
2019
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Luca Russo | 113 | 151 | 46 | 132 | 33 | 380 | |
| Xiao‐Qing Pei | 84 | 119 | 84 | 77 | 36 | 414 | |
| Mariël Brinkhuis | 44 | 99 | 43 | 78 | 32 | 436 | |
| W. Jäger | 42 | 86 | 44 | 170 | 40 | 402 | |
| Silvia Gigli | 95 | 196 | 65 | 38 | 24 | 386 | |
| Seyran Yiğit | 54 | 61 | 72 | 179 | 41 | 418 | |
| Ermanno Vanzi | 31 | 138 | 99 | 71 | 31 | 419 | |
| Alina Abramian | 58 | 62 | 54 | 158 | 30 | 355 | |
| Hongyu Zhou | 69 | 80 | 56 | 89 | 32 | 393 | |
| Femke van der Leij | 40 | 127 | 62 | 164 | 33 | 447 | |
| Christina Kaiser | 46 | 137 | 34 | 138 | 25 | 382 |
All Works
Login with ORCID to disown or claim papers
Loading papers...